Condition 1: Bacteriuria. Condition 2: CVA. Urinary tract infection, site not specified Stroke, not specified as haemorrhage or infarction
Conditions
Interventions
Intervention 1: Intervention Group: 25 patients in intervention group with chlorhexidine, daily, 5 minutes for up to 10 days of meatus region will be washed by using a sterile swab and a rotary washi
Prevention
Intervention Group: 25 patients in intervention group with chlorhexidine, daily, 5 minutes for up to 10 days of meatus region will be washed by using a sterile swab and a rotary washing will be perfo
Control group: included 25 patients with daily Normal Salin, 5 mintues for maximum 10 days, were washed.Using a sterile swab and a rotary washing will be performed.
Intervention group 2: 25 patients with Betadine will daily, 5 minutes for up to 10 days of meatus region will be washed .Using a sterile swab and a rotary washing will be performed.
Sponsors
Qazvin University Of Medical Sciences-nursnig and midwifery faculty-Vice-Chancellor for Research
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: every patient should be Catheterized 24 hours ago; they must be admitted in Neurology ward; before admission, none of the subjects must not have urinary tract infections, or diseases that affect urine output such as renal failure etc; all of patients must suffer from CVA diseases; they must not have visible urinary tract disease; patients in group one must not have a history of allergy to Chlorhexidine and patients in group two must not have a history of allergy to povidone iodine. Exclusion criteria: if the samples of complete urine analysis and culture are positive on the first day (more than 100,000 colonies per milliliter in urine, or more than 3WBC/hpf in the samples; if the patient is carried out before the fifth day of intervention(before taking the second sample); patients who don't consent to participate in the study were excluded; if patients show allergic reaction to any of the ingredients (povidone iodine / chlorhexidine) in the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bacteriuria and pyuria of urine analysis. Timepoint: On the first, fifth and tenth days. Method of measurement: Colonies per milliliter of urine and = 3 WBC / Hpf.;Positive urine culture. Timepoint: In the first, fifth and tenth days. Method of measurement: Urine analysis and urine culture. | — |
Secondary
| Measure | Time frame |
|---|---|
| Demographic questionnaire. Timepoint: First day. Method of measurement: Questionnaire.;Scale NIHSS. Timepoint: First Day. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactYasin Azadmanesh
Qazvin University of Medical Sciences
Outcome results
None listed